We are live on ! Find out more
AL

Agran Libbie Portfolio holdings

AUM $425M
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+16.08%
3 Year Est. Return
+27.53%
5 Year Est. Return
10 Year Est. Return
AUM
$425M
AUM Growth
+$12.4M
Cap. Flow
-$6.8M
Cap. Flow %
-1.6%
Top 10 Hldgs %
30.4%
Holding
133
New
7
Increased
36
Reduced
66
Closed
10

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$2.91M
2
DEI icon
Douglas Emmett
DEI
+$1.28M
3
KMI icon
Kinder Morgan
KMI
+$526K
4
AMLP icon
Alerian MLP ETF
AMLP
+$388K
5
MRK icon
Merck
MRK
+$344K

Sector Composition

Rank Sector Weight
1 Financials 16.07%
2 Technology 16.01%
3 Energy 12.6%
4 Healthcare 11.25%
5 Communication Services 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLS icon
101
Flowserve
FLS
$8.63B
$369K 0.09%
7,625
-3,570
-32% -$173K
PM icon
102
Philip Morris
PM
$297B
$369K 0.09%
3,266
-22
-0.7% -$2.27K
MIDD icon
103
Middleby
MIDD
$5.94B
$368K 0.09%
2,700
EOG icon
104
EOG Resources
EOG
$76B
$359K 0.08%
3,685
+1,050
+40% +$105K
TRP icon
105
TC Energy
TRP
$71.1B
$348K 0.08%
7,550
MO icon
106
Altria Group
MO
$123B
$314K 0.07%
4,392
-50
-1% -$3.62K
PFE icon
107
Pfizer
PFE
$142B
$314K 0.07%
+9,674
New +$305K
SLB icon
108
SLB Ltd
SLB
$69.4B
$309K 0.07%
3,957
+700
+21% +$57.2K
JCI icon
109
Johnson Controls International
JCI
$86.9B
$307K 0.07%
7,297
-725
-9% -$30.7K
CRM icon
110
Salesforce
CRM
$139B
$303K 0.07%
3,675
-100
-3% -$7.99K
GD icon
111
General Dynamics
GD
$100B
$271K 0.06%
1,450
+100
+7% +$18.5K
NSC icon
112
Norfolk Southern
NSC
$75B
$253K 0.06%
2,260
-75
-3% -$8.77K
AGN
113
DELISTED
Allergan plc
AGN
$253K 0.06%
+1,060
New +$247K
IDXX icon
114
Idexx Laboratories
IDXX
$43.6B
$247K 0.06%
+1,600
New +$221K
MRVL icon
115
Marvell Technology
MRVL
$189B
$238K 0.06%
15,600
NVS icon
116
Novartis
NVS
$296B
$223K 0.05%
3,344
-83
-2% -$5.53K
OKE icon
117
Oneok
OKE
$58B
$213K 0.05%
+3,850
New +$212K
DUK icon
118
Duke Energy
DUK
$97.5B
$209K 0.05%
2,552
-83
-3% -$6.6K
ROP icon
119
Roper Technologies
ROP
$35.6B
$208K 0.05%
+1,005
New +$201K
ECL icon
120
Ecolab
ECL
$75.1B
$201K 0.05%
1,600
-207
-11% -$25.3K
CPRX
121
DELISTED
Catalyst Pharmaceutical
CPRX
$86K 0.02%
44,000
ARWR icon
122
Arrowhead Research
ARWR
$10.4B
$38K 0.01%
20,600
AIXC
123
AIxCrypto Holdings Inc
AIXC
$15.7M
0
MMLP icon
124
Martin Midstream Partners
MMLP
$91.6M
-17,809
Closed -$3.18M
NVO
125
Novo Nordisk
NVO
$218B
-12,900
Closed -$231K

Similar funds

Agran Libbie's Q1 2017 Portfolio in Review

As of Q1 2017, Agran Libbie held 133 positions worth $425M, up 3% from $413M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Agran Libbie's Q1 2017 filing shows 7 new, 36 increased, 66 reduced and 10 closed positions. Its largest new stake was 3M: 18,943 shares worth $3.03M. The largest sale was Martin Midstream Partners, an estimated $3.18M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Energy.

  • Agran Libbie's largest Q1 2017 buy was 3M: 18,943 shares worth $3.03M.
  • Agran Libbie added most to Kinder Morgan in Q1 2017, an estimated $526K increase.
  • Agran Libbie's biggest Q1 2017 reduction was Donaldson, cutting an estimated $1.61M.
  • Agran Libbie fully exited Martin Midstream Partners in Q1 2017, selling an estimated $3.18M.
  • Agran Libbie's ten largest holdings make up 30% of its $425M portfolio in Q1 2017.
  • Agran Libbie opened 7 new positions and closed 10 in Q1 2017.
  • Agran Libbie's portfolio value rose 3% quarter-over-quarter to $425M.

Based on Agran Libbie's 13F filing for Q1 2017, filed 27 Apr 2017.